Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Aclaris Therapeutics Ownership Summary

Aclaris Therapeutics is owned by 74.34% institutional investors, 2.66% insiders, and 23.01% retail investors. Bml capital management is the largest institutional shareholder, holding 18.27% of ACRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Aclaris Therapeutics shares.

ACRS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aclaris Therapeutics	74.34%	2.66%	23.01%
Sector	Healthcare Stocks	47.38%	7.99%	44.63%
Industry	Diagnostics & Research Stocks	47.68%	7.65%	44.68%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bml capital management	12.99M	18.27%	$14.29M
Vanguard group	4.69M	6.60%	$5.16M
Millennium management	3.34M	4.69%	$3.67M
D. e. shaw	3.32M	4.67%	$3.65M
Rock springs capital management lp	2.75M	3.87%	$3.03M
Blackrock	2.03M	2.86%	$2.24M
Stonepine capital management	1.93M	2.71%	$2.12M
Acadian asset management	1.91M	2.69%	$2.10M
Trium capital llp	1.89M	2.66%	$2.08M
Two sigma advisers, lp	1.44M	2.02%	$1.58M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	12.99M	10.20%	$14.29M
Stonepine capital management	1.93M	1.93%	$2.12M
Aldebaran capital	858.15K	0.88%	$943.97K
Acuitas investments	464.12K	0.27%	$510.53K
Trium capital llp	1.89M	0.26%	$2.08M
Aisling capital management lp	434.45K	0.21%	$477.90K
Samsara biocapital	696.17K	0.16%	$765.79K
Rock springs capital management lp	2.75M	0.09%	$3.03M
Palo alto investors lp	569.83K	0.07%	$626.82K
Gsa capital partners llp	336.68K	0.03%	$370.00K

Top Buyers

Holder	Shares	% Assets	Change
Bml capital management	12.99M	10.20%	3.59M
Stonepine capital management	1.93M	1.93%	1.93M
Trium capital llp	1.89M	0.26%	1.89M
Aldebaran capital	858.15K	0.88%	858.15K
Goldman sachs group	916.62K	0.00%	770.81K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	2.03M	0.00%	-3.17M
State street	196.62K	-	-1.14M
Bain capital life sciences investors	-	-	-1.00M
Geode capital management	774.14K	0.00%	-790.92K
Renaissance	922.20K	0.00%	-751.20K

New Positions

Holder	Shares	% Assets	Change	Value
Stonepine capital management	1.93M	1.93%	1.93M	$2.12M
Trium capital llp	1.89M	0.26%	1.89M	$2.08M
Aldebaran capital	858.15K	0.88%	858.15K	$943.97K
Bridgeway capital management	150.70K	0.00%	150.70K	$165.77K
Y-intercept (hong kong)	114.81K	0.01%	114.81K	$126.29K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-14.00
Innealta capital	-56.00
Advisor group	-124.00
Truvestments capital	-150.00
Cornerstone planning group	-580.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	95	-3.06%	52,834,184	-2.94%	74	1.26%	41	-4.65%	37	-5.13%
Mar 31, 2024	98	-9.26%	54,434,983	-6.90%	76	1.13%	43	-29.51%	39	44.44%
Dec 31, 2023	108	-32.92%	58,470,532	-16.56%	82	0.84%	61	-28.24%	27	-25.00%
Sep 30, 2023	161	7.33%	70,071,814	-1.45%	99	0.88%	85	25.00%	36	-7.69%
Jun 30, 2023	150	-13.29%	71,102,857	-0.71%	106	0.93%	68	-20.00%	39	-7.14%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.12M	2.97%	-
Xtrackers S&P 500 Swap ETF 1C	923.31K	1.29%	-
Vanguard Institutional Extnd Mkt Idx Tr	820.73K	1.15%	-
Vanguard Strategic Small-Cap Equity Inv	706.50K	0.99%	-
Vanguard VIF Small Co Gr	639.02K	0.90%	-
SQUAD Aguja Opportunities I	500.00K	0.70%	-
iShares Biotechnology ETF	491.47K	0.69%	-2.94K
Fidelity Extended Market Index	412.84K	0.58%	198.27K
Vanguard Health Care ETF	225.47K	0.32%	-666.00
NT R2000 Growth Index Fund - NL	211.78K	0.30%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 02, 2024	Leonard Braden Michael	-	Buy	$216.40K
Aug 05, 2024	Leonard Braden Michael	-	Buy	$256.36K
Jul 31, 2024	Leonard Braden Michael	-	Buy	$132.64K
Jul 30, 2024	Leonard Braden Michael	-	Buy	$226.37K
Jul 22, 2024	Leonard Braden Michael	-	Buy	$23.56K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	11	-
2024 Q2	10	-
2024 Q1	2	-
2023 Q4	-	1

ACRS Ownership FAQ

Who Owns Aclaris Therapeutics?

Aclaris Therapeutics shareholders are primarily institutional investors at 74.34%, followed by 2.66% insiders and 23.00% retail investors. The average institutional ownership in Aclaris Therapeutics's industry, Diagnostics & Research Stocks, is 47.68%, which Aclaris Therapeutics exceeds.

Who owns the most shares of Aclaris Therapeutics?

Aclaris Therapeutics’s largest shareholders are Bml capital management (12.99M shares, 18.27%), Vanguard group (4.69M shares, 6.60%), and Millennium management (3.34M shares, 4.69%). Together, they hold 29.56% of Aclaris Therapeutics’s total shares outstanding.

Does Blackrock own Aclaris Therapeutics?

Yes, BlackRock owns 2.86% of Aclaris Therapeutics, totaling 2.03M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 2.24M$. In the last quarter, BlackRock decreased its holdings by -3.17M shares, a -60.94% change.

Who is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested, with 10.20% of its assets in 12.99M Aclaris Therapeutics shares, valued at 14.29M$.

Who is the top mutual fund holder of Aclaris Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aclaris Therapeutics shares, with 2.97% of its total shares outstanding invested in 2.12M Aclaris Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools